| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,532 | 52,020 | 39,914 | 71,550 | | Cost of Revenue | 40,807 | 32,940 | 26,504 | 43,349 | | | Gross Profit | 24,725 | 19,080 | 13,410 | 28,201 | | | Operating Expenses | | Research Development | 15,222 | 13,630 | 13,738 | 17,031 | | Selling General and Administrative | 8,320 | 8,211 | 8,330 | 10,123 | | Non Recurring |
-
|
-
|
-
| 181,534 | | Others | 3,072 | 3,058 | 3,047 | 5,653 | | | | Total Operating Expenses |
-
|
-
|
-
| 214,341 | | | | Operating Income or Loss | (1,889) | (5,819) | (11,705) | (186,140) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,113 | 581 | 603 | 2,353 | | Earnings Before Interest And Taxes | (776) | (5,238) | (11,102) | (183,787) | | Interest Expense |
-
|
-
|
-
| 4,141 | | Income Before Tax | (776) | (5,238) | (11,102) | (187,928) | | Income Tax Expense | (7,579) | (3,561) | (411) | 6,477 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,803 | (1,677) | (10,691) | (194,405) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,803 | (1,677) | (10,691) | (194,405) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,803 | ($1,677) | ($10,691) | ($194,405) |
|
0.51% Nasdaq 
Income Statement
